NICE director exercises options for 554 shares
NICE Ltd. director Zehava Simon exercised stock options covering 554 Ordinary Shares on 2026-08-13 at an exercise price of $0.3076 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
NICE Ltd. director Zehava Simon exercised stock options covering 554 Ordinary Shares on 2026-08-13 at an exercise price of $0.3076 per share. The option, which was fully vested and exercisable, was fully converted, leaving 0 options from this grant and resulting in 4,689 Ordinary Shares held directly after the transaction.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Options F1 | 554 | $0.00 | $0.00 |
| Exercise | Ordinary Shares | 554 | $0.3076 | $170.41 |
Footnotes (1)
- F1. The stock option is fully vested and currently exercisable.
Key Figures
Key Terms
Exercise or conversion of derivative security financial
fully vested financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did NICE (NICE) director Zehava Simon report in this Form 4?
How many NICE (NICE) options did Zehava Simon exercise and at what price?
What happened to the NICE (NICE) stock options involved in this Form 4?
Was the NICE (NICE) Form 4 transaction by Zehava Simon a market buy or sell?
AI-generated analysis. How Rhea-AI works. Not financial advice.